These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3354412)

  • 1. Absence of significant postdefibrillation bradyarrhythmias in patients with automatic implantable defibrillators.
    Niazi I; Kadri N; Mahmud R; Jazayeri M; Denker S; Werner P; Akhtar M; Tchou P
    Am Heart J; 1988 Apr; 115(4):830-6. PubMed ID: 3354412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation.
    Khastgir T; Lattuca J; Aarons D; Murphy J; O'Mara V; Juanteguy J; Veltri EP
    Pacing Clin Electrophysiol; 1991 May; 14(5 Pt 1):768-72. PubMed ID: 1712951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between shock energy and postdefibrillation ventricular arrhythmias in patients with implantable defibrillators.
    Zivin A; Souza J; Pelosi F; Flemming M; Knight BP; Goyal R; Morady F; Strickberger SA
    J Cardiovasc Electrophysiol; 1999 Mar; 10(3):370-7. PubMed ID: 10210500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of drug therapy on frequency of adequate discharges of implanted cardioverter defibrillator].
    Tiroke A; Ganeeva ON
    Kardiologiia; 2003; 43(6):54-8. PubMed ID: 12891312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias.
    Kelly PA; Cannom DS; Garan H; Finkelstein D; McComb JM; Mirabal GS; Ilvento JP; Ruskin JN
    Am J Cardiol; 1988 Jul; 62(1):83-7. PubMed ID: 3381756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The automatic implantable cardioverter-defibrillator: efficacy, complications, and device failures.
    Marchlinski FE; Flores BT; Buxton AE; Hargrove WC; Addonizio VP; Stephenson LW; Harken AH; Doherty JU; Grogan EW; Josephson ME
    Ann Intern Med; 1986 Apr; 104(4):481-8. PubMed ID: 3954276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F; Moubarak G; Savouré A; Godin B; Borz B; Drouin-Garraud V; Gay A
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of arrhythmias in patients with Takotsubo cardiomyopathy: Is the implantation of permanent devices necessary?
    Stiermaier T; Rommel KP; Eitel C; Möller C; Graf T; Desch S; Thiele H; Eitel I
    Heart Rhythm; 2016 Oct; 13(10):1979-86. PubMed ID: 27298201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sotalol in patients with implanted automatic defibrillators: effects on defibrillation and comparison with amiodarone.
    Dorian P; Newman D; Harris L; Downar E
    Can J Cardiol; 1994 Mar; 10(2):193-200. PubMed ID: 8143220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative hypothermia increased defibrillation energy requirements.
    Kapetanopoulos A; Katsetos MC; Kluger J
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):741-3. PubMed ID: 17700410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defibrillation testing is mandatory in patients with subcutaneous implantable cardioverter-defibrillator to confirm appropriate ventricular fibrillation detection.
    le Polain de Waroux JB; Ploux S; Mondoly P; Eschalier R; Strik M; Houard L; Pierre B; Buliard S; Klotz N; Ritter P; Haissaguerre M; Mahfouz K; Bordachar P
    Heart Rhythm; 2018 May; 15(5):642-650. PubMed ID: 29709229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.